A weight-corrected UAC of 109 males and 292 females with untreated thyrotoxicosis was compared with that of the same number of control subjects. Control subjects were chosen from the subjects without apparent diseases; one control for one patient with about the same age, height and weight. The mean value of the weight-corrected UAC in thyrotoxic patients was 25.4cm both in males and females. The mean value of the controls was 26.7cm in males and 26.0cm in females. These findings suggest that UAC of thyrotoxic patients is smaller than that of controls even in the same height and weight, and that there is a significant decrease of body muscle mass in thyrotoxic patients.
Although it is important to evaluate the degree of muscular wasting in dealing leanness, a simple method for this purpose has not been available. We have previously reported that when upper arm circumference (UAC) is corrected to the standard weight value by lineal regression equation between UAC and body weight expressed as percent deviation from the standard weight, this weight-corrected UAC is a good index of body muscle mass, and that the weight-corrected UAC declines with advancing age.
There is a considerable number of studies on thyrotoxic myopathy, but little work has been done to show the change in muscle mass in thyrotoxic patients. In this paper we have attempted to calculate the weight-corrected UAC and evaluate whether body muscle mass of thyrotoxic patients is decreased or not, comparing them with control subjects. Since it is well known that patients with Cushing's syndrome have decreased UAC, an observation about patients who have received long term steroid therapy has also been made in this study.
Materials and Methods
The subjects were untreated patients with thyrotoxic diffuse goiter, 109 males and 292 females. The average age of the male patients was 38 years, including 25 cases aged 20-29, 36 aged 30-39, 33 aged 40-49, and 15 aged 50-59. The average age of the female patients was 35 years, including 105 aged 20-29, 96 aged 30-39, 63 aged 40-49 and 28 aged 50-59. Control subjects were chosen from the subjects without thyrotoxicosis and other apparent diseases; one control for one patient with about the same age, height and weight. UAC was measured at right mid-upper arm in a vertical position. As the standard weight is used the heightweight table, reported preciously (Matsuki and Yoda, 1972) . The weight was expressed as percent deviation from the standard weight.
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Results
The correlations between UAC and weight deviation are presented in Figure 1 (male thyrotoxic patients) and Figure 2 (female thyrotoxic patients). The correlation coefficients were 0.78 in the former and 0.94 in the latter. There are both highly significant correlations between UAC and weight deviation. Table 2 . The differences between thyrotoxic patients and controls in males and in females are statistically significant (both p<0.001). These findings suggest that UAC of thyrotoxic patients is smaller than that of controls even in the same height and weight, and that there is a significant decrease of body muscle mass in thyrotoxic patients. The mean value of the weightcorrected UAC in male thyrotoxic patients was about the same as that in female patients, while the weight-corrected UAC in male controls was larger than that in female controls. This finding suggests that the decrease of body muscle mass in male thyrotoxic patients is more pronounced than that in female patients. received long term steroid therapy. All cases had no edema. The weight-corrected UAC was calculated from the linear regression equation of the male control subjects. a high degree of the decrease of the weight-corrected UAC was found in all patients who had received steroid therapy, being compared with that of the male controls presented in Table 2 .
Discussion
There is a significant relationship between UAC and percent weight deviation from the standard, and the linear correlation is obtained by a regression equation. The weightcorrected UAC calculated from the regression equation is a good index for body muscle mass and declines with advancing age (Matsuki and Yoda, 1972) .
As presented in Figure 1 (male thyrotoxic patients) and Figure 2 (female thyrotoxic patients), there are in both figures highly significant correlations between UAC and weight deviation. The weight-corrected UAC was calculated from linear regression equations of thyrotoxic patients and controls presented in Table 1 . The mean value of the weight-corrected UAC in thyrotoxic patients was 25.4cm both in males and females. While the mean value of controls was 26.7cm in males and 26.0cm in females. From the above results it is found that the body muscle mass is decreased in thyrotoxic patients, especially in males, since the weight-corrected UAC is thought to be a good indicator of body muscle mass.
It is well known that thyroid hormone has a significant effect on skeletal muscles, and that decreased muscle strength and muscle atrophy are common in thyrotoxic patients. In the past, thyrotoxicosis with significant muscle disorders was classified as a specific disease, thyrotoxic myopathy (Zierler, 1951; Whitfield and Hudson, 1961) . However, recently it has been reported that myopathy is common in thyrotoxic patients (Millikan and Haines, 1953; Hed et al., 1958; Ramsay, 1966) , and Satoyoshi et al. (1963) reported that the skeletal muscles are always more or less impaired in thyrotoxicosis. There have been many reports concerning the abnormal findings of the E.M.G. (Sanderson and Adey, 1952; Havard et al., 1963; Ramsay, 1965) , the pathohistological changes of the muscles (Whitfield and Hudson, 1961; Hed et al., 1958; Engel, 1966; Havard et al., 1963) , the biochemical findings such as creatine and creatinine metabolism and serum electrolyte (Satoyoshi et al., 1963; Graig and Smith, 1965; Hoch, 1968) , and muscle disorders suggested by the decrease of grasping power and dorsal muscular force (Satoyoshi, 1961; Aoki, 1963) in thyrotoxic myopathy, but there are very few reports concerning the changes in the amount of muscle in thyrotoxicosis. Usually, weight loss is due to loss of lean body mass as well as loss of fat. It was found that the loss of muscle mass plays a larger role in the loss of weight in thyrotoxic patients than in normal subjects by meaning the weight-corrected UAC. The result that the decrease of body muscle mass in male thyrotoxic patients is more pronounced than that in female patients may be related to the fact that there is less muscle in females than males.
As presented in Table 3 , the weightcorrected UAC of patients who have received a long term steroid therapy are smaller in each case than that of the male controls shown in Table 2 . It is suspected that this may depend on the decrease of body muscle mass due to a long term steroid therapy, although we cannot rule out malnutrition caused by the underlying diseases. It is well known that steroid hormone causes protein catabolism as a physical action. Cushing's syndrome which is caused by the excessive secretion of steroid hormone, is characterized by the abnormal slenderness of the extremities despite of the trunkal obesity, and this finding may suggest that there is a decrease of the body muscle mass caused by the steroid excess in this syndrome. Although most of the cases shown in Table 3 have their lean body, it may be demonstrated by using the weight-corrected UAC of the cases that the body muscle mass is actually decreased in the cases with the gained weight on steroid therapy.
